Antonio Marchetti, Professor of Pathology and Director, Center of Predictive Molecular Medicine

7 April 2017

Genomics in Oncology lecture series invites Antonio Marchetti, Professor of Pathology and Director of the Center of Predictive Molecular Medicine at the University of Chieti in Italy. Professor Marchetti presents his research with liquid biopsies in lung cancer and shares his perspective on the future of applying next-generation sequencing technology in plasma to drive the future of personalized medicine. Learn more about Genomics in Oncology, visit our website: A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. Subscribe to the Illumina video channel View customer spotlight videos View Illumina webinars View Illumina product videos View Illumina support videos

Share this article on